The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastomaMin Pan, Paul Geeleher, William C. Wright et al.|Nature Communications|2021Cited by 95
Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell linesGisele Nishiguchi, Zoran Ranković, Zhe Shi et al.|Nature Communications|2024Cited by 50
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastomaMin Pan, Paul Geeleher, William C. Wright et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 6
Rationally Designed Potent and Selective CK1α Degraders Exert Antiproliferative Activity Against a Broad Range of Human Cancer Cell LinesZoran Ranković, Anthony A. High, Gisele Nishiguchi et al.|Research Square|2023Cited by 0
Selective CK1a Degraders Exert Antiproliferative Activity Against a Broad Range of Human Cancer Cell LinesGisele Nishiguchi, Zoran Ranković, Lauren G. Mascibroda et al.|Figshare|2024Cited by 0